Accredo, your partner in specialized rare therapies care.

Accredo’s Rare Disease Therapeutic Resource Center® (TRC) operates as an individual center of excellence within Accredo and is one of a limited number in the U.S. with the URAC Center of Excellence Rare Disease accreditation. This accreditation assures you that Accredo delivers condition-specific care from highly trained experts to support their patients and therapy.

Patients and prescribers have personalized access to pharmacists, nurses, dietitians, social workers and other patient support personnel through our Rare Disease TRC by phone or chat message.

In 2022:

• 25% of rare disease patients or caregivers received a social worker assessment.
• 71% of rare disease patients or caregivers discussed therapy and quality of life goals with a clinician.
• Social workers performed 673 social worker interventions (14% of rare disease patients) and 365 dietitian interventions (4% of rare disease patients) with no charge to patients, payers or manufacturers.

At Accredo, we understand that rare medications are time sensitive and access to these meds are critical to the health and well-being of your patients.

• The patient access team at Accredo works closely with prescribers to gather necessary clinical data for referral support.
• Accredo has relationships with multiple payers and access to limited and exclusive therapies.
• Accredo’s relationships with a multitude of payers, plus access to many limited and exclusive therapies, means we have experience in supporting prior authorization and reauthorization.
• 99,2% of reauthorization cases are completed before patients exhaust their medication, ensuring no therapy gaps.

Recent estimates report the mean cost of developing a new drug for a rare condition can range from $314 million to $2,8 billion dollars.1 Smaller patient populations with rare and ultra-orphan conditions could pay a high price for therapies that are often times life-saving. Accredo aims to help patients access and maintain therapy and secured and applied $2,9 billion in assistance for patients in 2024. Accredo provides social worker support for financial assistance with utilities, food, mobility, transportation, and more to remove barriers to therapy.

• 1Source: JAMA Network: 2 de marzo de 2020

Recent estimates report the mean cost of developing a new drug for a rare condition can range from $314 million to $2,8 billion dollars.1 Smaller patient populations with rare and ultra-orphan conditions could pay a high price for therapies that are often times life-saving. Accredo aims to help patients access and maintain therapy and secured and applied $2,9 billion in assistance for patients in 2024. Accredo provides social worker support for financial assistance with utilities, food, mobility, transportation, and more to remove barriers to therapy.

• 1Source: JAMA Network: 2 de marzo de 2020

Puede enviarnos la receta de su paciente a través de cuatro medios:

• Recetas digitales (a través de registros médicos electrónicos)
• ePrescribe (via MyAccredoPatients.com)
• Send us an Electronic Referral
• Fax: Using a referral from PDF, you can complete the form and fax to the number indicated on the referral form.
• Teléfono: To submit a prescription by phone, please call 866-759-1557.

Visit Manage Referrals | Accredo for more detail.